Short communication: High prevalence of vitamin D deficiency in HIV-infected and hiv-uninfected pregnant women

AIDS Research and Human Retroviruses

Volumn 29, Issue 9, 2013, Pages 1224-1228

  Eckard, Allison Ross ^a,b   Leong, Traci ^c   Avery, Ann ^d,e   Castillo, Marina Duran ^d   Bonilla, Hector ^f   Storer, Norma ^e,g   Labbato, Danielle ^e,g   Khaitan, Alka ^e,g   Tangpricha, Vin ^a   Mccomsey, Grace A ^e,g  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c EMORY UNIVERSITY   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f SUMMA HEALTH SYSTEM   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VITAMIN D;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ETHNICITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATERNAL AGE; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; UMBILICAL CORD BLOOD; VITAMIN D DEFICIENCY;

CD4 LYMPHOCYTE COUNT; FEMALE; FETAL BLOOD; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84882979996     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0384     Document Type: Article

References (45)

1. Ross AC, Judd S, Kumari M, et al.: Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther 2011;16(4):555- 563.
2. Eckard AR, Judd SE, Ziegler TR, et al.: Risk factors for vitamin D deficiency and relationship with cardiac biomarkers, inflammation and immune restoration in HIV-infected youth. Antivir Ther 2012;17(6):1069-1078.
3. Brown TT and McComsey GA: Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010;15(3):425-429.
4. Viard JP, Souberbielle JC, Kirk O, et al.: Vitamin D and clinical disease progression in HIV infection: Results from the EuroSIDA study. AIDS 2011;25(10):1305-1315.
5. Mehta S, Giovannucci E, Mugusi FM, et al.: Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010;5(1): E8770.
6. Mehta S, Hunter DJ, Mugusi FM, et al.: Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009;200(7):1022-1030.
7. Holick MF: Vitamin D deficiency. N Engl J Med 2007; 357(3):266-281.
8. Hollis BW and Pittard WB 3rd: Evaluation of the total fetomaternal vitamin D relationships at term: Evidence for racial differences. J Clin Endocrinol Metab 1984;59(4): 652-657.
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.: Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(7):1911-1930.
10. Institute of Medicine (U.S.): Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, Washington, DC, 2011.
11. Ganji V, Zhang X, and Tangpricha V: Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assayadjusted data. J Nutr 2012;142(3):498-507.
12. Ginde AA, Sullivan AF, Mansbach JM, and Camargo CA Jr: Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol 2010;202(5):436 e431-438.
13. Urrutia RP and Thorp JM: Vitamin D in pregnancy: Current concepts. Curr Opin Obstet Gynecol 2012;24(2):57-64.
14. Adeyemi OM, Agniel D, French AL, et al.: Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr 2011;57(3): 197-204.
15. Del Bino S, Sok J, Bessac E, and Bernerd F: Relationship between skin response to ultraviolet exposure and skin color type. Pigment Cell Res 2006;19(6):606-614.
16. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, and Koerfer R: Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: A double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83(4):754-759.
17. Kamen DL and Tangpricha V: Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J Mol Med (Berl) 2010;88(5):441-450.
18. van Etten E, Stoffels K, Gysemans C, Mathieu C, and Overbergh L: Regulation of vitamin D homeostasis: Implications for the immune system. Nutr Rev 2008;66(10 Suppl 2): S125-134.
19. Khazai N, Judd SE, and Tangpricha V: Calcium and vitamin D: Skeletal and extraskeletal health. Curr Rheumatol Rep 2008;10(2):110-117.
20. Wang TT, Tavera-Mendoza LE, Laperriere D, et al.: Largescale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005; 19(11):2685-2695.
21. Liu PT, Stenger S, Tang DH, and Modlin RL: Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007;179(4):2060-2063.
22. Yuk JM, Shin DM, Lee HM, et al.: Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009;6(3):231-243.
23. Bergman P, Walter-Jallow L, Broliden K, Agerberth B, and Soderlund J: The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 2007;5(4):410-415.
24. Campbell GR and Spector SA: Hormonally active vitamin D3 (1alpha,25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J Biol Chem 2011;286(21):18890-18902.
25. Burris HH, Rifas-Shiman SL, Kleinman K, et al.: Vitamin D deficiency in pregnancy and gestational diabetes mellitus. Am J Obstet Gynecol 2012;207(3):182 e181-188.
26. Poel YH, Hummel P, Lips P, Stam F, van der Ploeg T, and Simsek S: Vitamin D and gestational diabetes: A systematic reviewandmeta-analysis. Eur J InternMed 2012;23(5):465-469.
27. Sorensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, and Stene LC: Maternal serum levels of 25-hydroxy-vitamin D during pregnancy and risk of type 1 diabetes in the offspring. Diabetes 2012;61(1):175-178.
28. Hitti J, Andersen J, McComsey G, et al.: Protease inhibitorbased antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084. Am J Obstet Gynecol 2007;196(4):331 e331-337.
29. Dapena M, Jimenez B, Noguera-Julian A, et al.: Metabolic disorders in vertically HIV-infected children: Future adults at risk for cardiovascular disease. J Pediatr Endocrinol Metab 2012;25(5-6):529-535.
30. Brown TT, Cole SR, Li X, et al.: Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165(10): 1179-1184.
31. Brown TT, Li X, Cole SR, et al.: Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 2005;19(13):1375-1383.
32. Geffner ME, Patel K, Miller TL, et al.: Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr 2011;76(6):386-391.
33. Bockhorst JL, Ksseiry I, Toye M, et al.: Evidence of human immunodeficiency virus-associated lipodystrophy syndrome in children treated with protease inhibitors. Pediatr Infect Dis J 2003;22(5):463-465.
34. Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, and Kline MW: Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J 2002; 21(5):405-410.
35. Hollis BW and Wagner CL: Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004;79(5):717-726.
36. Brooke OG, Brown IR, Bone CD, et al.: Vitamin D supplements in pregnant Asian women: Effects on calcium status and fetal growth. Br Med J 1980;280(6216):751-754.
37. Brooke OG, Butters F, and Wood C: Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br Med J (Clin Res Ed) 1981;283(6298):1024.
38. Wagner CL, Taylor SN, Dawodu A, Johnson DD, and Hollis BW: Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients 2012;4(3): 208-230.
39. Burris HH, Rifas-Shiman SL, Camargo CA Jr, et al.: Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Ann Epidemiol 2012;22(8):581-586.
40. Pawley N and Bishop NJ: Prenatal and infant predictors of bone health: The influence of vitamin D. Am J Clin Nutr 2004;80(6 Suppl):1748S-1751S.
41. Belderbos ME, Houben ML, Wilbrink B, et al.: Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 2011;127(6):e1513-1520.
42. Houben ML, Bont L, Wilbrink B, et al.: Clinical prediction rule for RSV bronchiolitis in healthy newborns: Prognostic birth cohort study. Pediatrics 2011;127(1):35-41.
43. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, and Hunninghake GW: Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184(2):965-974.
44. McGrath J: Does 'imprinting' with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001;56(3):367-371.
45. Watts DH: Treating HIV during pregnancy: An update on safety issues. Drug Saf 2006;29(6):467-490.